David L. Brinkley, Head of Business Development at THERAVANCE INC (THRX), sold 1,956 shares at $13.01 ($25K) on 2009-12-16, disclosed to the SEC on 2009-12-18.
Open-market sale of $25k THRX by Head of Business Development. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| THRX | SELL | 2013-05-07 | $561K | — | Filing → |
| THRX | SELL | 2013-05-02 | $577K | — | Filing → |
| THRX | SELL | 2012-08-28 | $96K | — | Filing → |